Ionic Liquid One-Pot Synthesis of Warfarin
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for synthesizing Warfarin face challenges such as prolonged reaction duration, low product yields, and dependency on toxic solvents, necessitating a solvent-free, high-yield, and efficient synthesis process.
Innovation Solution
A one-pot reaction method involving a liquid mixture of trihexyltetradecylphosphonium bromide, methyl salicylate, acetyl chloride, benzaldehyde, and acetone, incubated at ambient temperature, followed by the addition of water to form (RS)-Warfarin, which reduces reaction time and eliminates the need for solvents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional methods are used to synthesize Warfarin, then the reaction can proceed with standard reagents, but the reaction duration is prolonged and product yields are low
Solution Approach 1:
The patent employs ionic liquids as intermediary substances to facilitate the synthesis reaction. Specifically, the ionic liquid acts as a catalyst and solvent medium that enables the condensation reaction between 4-hydroxycoumarin and benzylideneacetone to proceed more efficiently, thereby reducing reaction time while maintaining or improving product yield.
Solution Approach 2:
The patent modifies reaction parameters by conducting the synthesis at ambient temperature rather than requiring elevated temperatures. This parameter change, combined with the use of ionic liquids, optimizes the reaction conditions to achieve faster reaction rates and improved yields without compromising the reliability of the synthesis process.
2Ease of manufacture
If conventional solvents are used in Warfarin synthesis, then the reaction can proceed smoothly, but toxic solvent dependency increases and environmental impact worsens
Solution Approach 1:
The patent extracts or removes traditional toxic organic solvents from the reaction system and replaces them with ionic liquids. This extraction of harmful substances eliminates the dependency on toxic solvents while maintaining the reaction's smooth progression, thereby resolving the contradiction between ease of manufacture and environmental harm.
Solution Approach 2:
The patent creates an inert or environmentally benign reaction environment by using ionic liquids as the reaction medium. This inert environment, free from toxic volatile organic compounds, allows the reaction to proceed smoothly without the harmful effects associated with conventional solvents, thus reducing environmental impact while maintaining manufacturing ease.
3Reliability
If multiple steps are used in Warfarin synthesis, then the reaction can be controlled precisely, but the process complexity increases and efficiency decreases
Solution Approach 1:
The patent merges multiple reaction steps into a single one-pot synthesis procedure. By combining the condensation reaction and subsequent transformations in one continuous process using ionic liquids, the method maintains precise reaction control through the stabilizing effect of the ionic liquid medium while significantly improving synthesis efficiency by eliminating intermediate isolation and purification steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves high yields of Warfarin with reduced reaction time and environmental impact, while minimizing reactant consumption and toxic solvent use, resulting in a more efficient and environmentally friendly synthesis process.
Implementation Method 1
an exemplary method may comprise preparing an exemplary liquid mixture comprising trihexyltetradecylphosphonium bromide, methyl salicylate, acetyl chloride, benzaldehyde, and acetone
Implementation Method 2
forming an exemplary (RS)-Warfarin by adding water to an exemplary incubated liquid mixture with a volume ratio (water:incubated liquid mixture) between 1:1 and 1.5:1
Data Source
AI summary
A method for synthesizing (RS)-Warfarin comprising preparing a liquid mixture, wherein the liquid mixture comprises trihexyltetradecylphosphonium bromide, methyl salicylate, acetyl chloride, benzaldehyde, and acetone. The method may further comprise incubating the liquid mixture at a temperature between 20° C. and 30° C. for a time duration between 26 and 34 minutes, and forming (RS)-Warfarin by adding water to the incubated liquid mixture with a volume ratio (water:incubated liquid mixture) between 1:1 and 1.5:1.